Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank77
3Y CAGR-21.0%
Studio
Year-over-Year Change

Year-over-year net income growth rate

3Y CAGR
-21.0%/yr
Quarterly compound
Percentile
P77
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q3 20258.96%
Q2 20250.59%
Q1 202511.33%
Q4 2024-22.35%
Q3 20243.34%
Q2 2024-6.52%
Q1 2024-34.91%
Q4 2023-44.88%
Q3 2023-62.51%
Q2 202357.45%
Q1 2023-0.44%
Q4 20220.11%
Q3 202218.16%
Q2 20224.88%
Q1 202214.14%
Q4 2021-29.88%
Q3 2021-25.98%
Q2 2021-46.89%
Q1 2021-0.45%
Q4 2020-21.98%
Q3 2020-368.85%
Q2 2020158.98%
Q1 20200.00%